Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Grazia Valsecchi

Showing results (21-30 of 326) with videos related to

Pageof 33
Sort By:
Archives of Public Health = Archives Belges De Sante Publique|January 26, 2021
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 casesAnita Andreano, Maria Grazia Valsecchi, Antonio Giampiero Russo, et al.
Biometrical Journal. Biometrische Zeitschrift|October 6, 2018
Graphical representations and summary indicators to assess the performance of risk predictorsLaura Antolini, Elena Tassistro, Maria Grazia Valsecchi, et al.
BMC Medical Research Methodology|January 13, 2016
Crude incidence in two-phase designs in the presence of competing risksPaola Rebora, Laura Antolini, David V Glidden, et al.
Pediatric Blood & Cancer|May 9, 2007
Web-based international studies in limited populations of pediatric leukemiaMaria Grazia Valsecchi, Daniela Silvestri, Anna Covezzoli, et al.
Breast Cancer Research and Treatment|April 3, 2017
Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approachAnita Andreano, Paola Rebora, Maria Grazia Valsecchi, et al.
BMC Medical Research Methodology|January 3, 2024
Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysisElena Tassistro, Davide Paolo Bernasconi, Maria Grazia Valsecchi, et al.
British Journal of Haematology|August 5, 2011
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemiaGiovanni Cazzaniga, Maria Grazia Valsecchi, Giuseppe Gaipa, et al.
Health and Quality of Life Outcomes|May 17, 2018
Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: the need to present minimal important differences units in meta-analysesSilvia Gianola, Anita Andreano, Greta Castellini, et al.
Nature Communications|March 15, 2022
A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disordersFrancesca Tucci, Stefania Galimberti, Luigi Naldini, et al.
Intensive Care Medicine|May 27, 2020
Frailty index predicts poor outcome in COVID-19 patientsGiuseppe Bellelli, Paola Rebora, Maria Grazia Valsecchi, et al.
Pageof 33

Showing results (21-30 of 326) with videos related to

Sort By:
Pageof 33
Archives of Public Health = Archives Belges De Sante Publique|January 26, 2021
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 casesAnita Andreano, Maria Grazia Valsecchi, Antonio Giampiero Russo, et al.
Biometrical Journal. Biometrische Zeitschrift|October 6, 2018
Graphical representations and summary indicators to assess the performance of risk predictorsLaura Antolini, Elena Tassistro, Maria Grazia Valsecchi, et al.
BMC Medical Research Methodology|January 13, 2016
Crude incidence in two-phase designs in the presence of competing risksPaola Rebora, Laura Antolini, David V Glidden, et al.
Pediatric Blood & Cancer|May 9, 2007
Web-based international studies in limited populations of pediatric leukemiaMaria Grazia Valsecchi, Daniela Silvestri, Anna Covezzoli, et al.
Breast Cancer Research and Treatment|April 3, 2017
Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approachAnita Andreano, Paola Rebora, Maria Grazia Valsecchi, et al.
BMC Medical Research Methodology|January 3, 2024
Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysisElena Tassistro, Davide Paolo Bernasconi, Maria Grazia Valsecchi, et al.
British Journal of Haematology|August 5, 2011
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemiaGiovanni Cazzaniga, Maria Grazia Valsecchi, Giuseppe Gaipa, et al.
Health and Quality of Life Outcomes|May 17, 2018
Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: the need to present minimal important differences units in meta-analysesSilvia Gianola, Anita Andreano, Greta Castellini, et al.
Nature Communications|March 15, 2022
A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disordersFrancesca Tucci, Stefania Galimberti, Luigi Naldini, et al.
Intensive Care Medicine|May 27, 2020
Frailty index predicts poor outcome in COVID-19 patientsGiuseppe Bellelli, Paola Rebora, Maria Grazia Valsecchi, et al.
Pageof 33